LADENBURG THALMANN FINANCIAL SERVICES INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$104,000
+188.9%
9,327
+47.4%
0.00%
Q3 2019$36,000
-47.8%
6,327
-21.2%
0.00%
Q2 2019$69,000
+23.2%
8,027
+15.9%
0.00%
Q1 2019$56,000
+194.7%
6,927
+46.5%
0.00%
Q4 2018$19,000
-40.6%
4,727
-17.5%
0.00%
Q3 2018$32,000
-60.5%
5,7270.0%0.00%
-100.0%
Q2 2018$81,0000.0%5,7270.0%0.00%0.0%
Q1 2018$81,000
+72.3%
5,7270.0%0.00%
Q4 2017$47,000
-30.9%
5,7270.0%0.00%
-100.0%
Q3 2017$68,000
+41.7%
5,727
+21.2%
0.00%0.0%
Q2 2017$48,000
+92.0%
4,727
+122.2%
0.00%
Q1 2017$25,000
+56.2%
2,127
-16.2%
0.00%
Q4 2016$16,000
-20.0%
2,5390.0%0.00%
Q3 2016$20,000
+25.0%
2,5390.0%0.00%
Q2 2016$16,000
+60.0%
2,539
+125.3%
0.00%
Q1 2016$10,000
-23.1%
1,1270.0%0.00%
Q4 2015$13,000
+18.2%
1,1270.0%0.00%
Q3 2015$11,000
-42.1%
1,1270.0%0.00%
Q2 2015$19,000
-62.7%
1,127
-65.6%
0.00%
-100.0%
Q1 2015$51,000
+50.0%
3,277
+54.1%
0.00%0.0%
Q4 2014$34,000
+88.9%
2,127
+23.2%
0.00%
Q3 2014$18,000
-30.8%
1,727
-38.3%
0.00%
-100.0%
Q2 2014$26,000
+36.8%
2,7970.0%0.00%0.0%
Q1 2014$19,000
+216.7%
2,797
+80.5%
0.00%
Q4 2013$6,0001,5500.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders